Literature DB >> 17598667

Clinical and laboratory characteristics of hospitalised patients with neurological manifestations of HIV/AIDS at the Nairobi hospital.

J O Jowi1, P M Mativo, S S Musoke.   

Abstract

OBJECTIVE: To determine the profile of clinical and laboratory characteristics of hospitalised HIV positive patients with neurological complications at a private hospital in Nairobi, Kenya from January 2000 to June 2005.
DESIGN: Retrospective observational study.
SETTING: The Nairobi Hospital, Nairobi, Kenya.
SUBJECTS: One hundred and fifty hospitalised patients.
RESULTS: Records of 708 HIV positive hospitalised patients were reviewed, 150 patients had neurological complications; giving a six-year point prevalence of 21.2%. Males were 86 (57.3%) and females 64 (42.7%) M:F ratio = 1.3:1. Mean age was 38.84 years. The five commonest neurological complications were; cryptococcal meningitis 33 (22%), encephalitis 28 (18.7%), cerebral toxoplasmosis 19 (12.7%), stroke 19 (12.7%) and tuberculous meningitis 16 (10.7%). Overall, 72 patients (63%) had CD4+ counts done. Cryptococcal meningitis patients' CD4+ count, (mean 60, median 17, range 1-273/cmm). Encephalitis patients' CD4+count, (mean 82, median 54, range 3-495/cmm). Cerebral toxoplasmosis patients' CD4+count, (mean 59, median 58, range 11-120/cmm). Stroke patients' CD4+ count, (mean 120, median 30, range 15-394/cmm) and Tuberculous meningitis patients' CD4+ count, (mean 67, median 62 and range 12-154/cmm). The other rare neurological manifestations included peripheral neuropathy, HIV associated dementia (HAD), myelopathy and myopathy amongst others. One hundred and eight (72%) patients were on anti-retroviral therapy. The commonest drugs used in various regimen combinations included efavirenz and combivir. Fourteen (9.3%) patients died while in hospital; eight of them were among those with the top five neurological complications.
CONCLUSION: The findings show that patients come to hospital when severely immune compromised and hence have overwhelming opportunistic infections. The profile of opportunistic infection is comparable to that observed in studies elsewhere. Some of the facts observed here may not reflect the situation in public health institutions where resources are scarce. RECOMMENDATION: To do a multi-centre prospective study of neurological manifestations of HIV/AIDS.

Entities:  

Mesh:

Year:  2007        PMID: 17598667     DOI: 10.4314/eamj.v84i2.9506

Source DB:  PubMed          Journal:  East Afr Med J        ISSN: 0012-835X


  16 in total

1.  Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

Authors:  K Robertson; H Jiang; J Kumwenda; K Supparatpinyo; S Evans; T B Campbell; R Price; S Tripathy; N Kumarasamy; A La Rosa; B Santos; M T Silva; S Montano; C Kanyama; S Faesen; R Murphy; C Hall; C M Marra; C Marcus; B Berzins; R Allen; M Housseinipour; F Amod; I Sanne; J Hakim; A Walawander; A Nair
Journal:  Clin Infect Dis       Date:  2012-06-01       Impact factor: 9.079

2.  A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings.

Authors:  Kevin Robertson; Johnstone Kumwenda; Khuanchai Supparatpinyo; Jeanne H Jiang; Scott Evans; Thomas B Campbell; Richard W Price; Robert Murphy; Colin Hall; Christina M Marra; Cheryl Marcus; Baiba Berzins; Reena Masih; Breno Santos; Marcus T Silva; N Kumarasamy; Ann Walawander; Apsara Nair; Srikanth Tripathy; Cecilia Kanyama; Mina Hosseinipour; Silvia Montano; Alberto La Rosa; Farida Amod; Ian Sanne; Cindy Firnhaber; James Hakim; Pim Brouwers
Journal:  J Neurovirol       Date:  2011-07-23       Impact factor: 2.643

Review 3.  Trends and Clinical Characteristics of HIV and Cerebrovascular Disease in Low- and Middle-Income Countries (LMICs) Between 1990 and 2021.

Authors:  George Ransley; Stanley Zimba; Yohane Gadama; Deanna Saylor; Laura Benjamin
Journal:  Curr HIV/AIDS Rep       Date:  2022-10-20       Impact factor: 5.495

4.  The prevalence, clinical features, risk factors and outcome associated with cryptococcal meningitis in HIV positive patients in Kenya.

Authors:  R Mdodo; K Brown; E Omonge; W Jaoko; J Baddley; P Pappas; M Colette Kempf; I Aban; S Odera; A Suleh; P E Jolly
Journal:  East Afr Med J       Date:  2010-12

5.  High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana.

Authors:  Japheth A Opintan; Benedict K Awadzi; Isaac J K Biney; Vincent Ganu; Richard Doe; Ernest Kenu; Rita F Adu; Mary M Osei; Amos Akumwena; Michael E Grigg; Gary A Fahle; Mercy J Newman; Peter R Williamson; Margaret Lartey
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-10-01       Impact factor: 2.184

6.  Cerebro-meningeal infections in HIV-infected patients: a study of 116 cases in Libreville, Gabon.

Authors:  Magloire Ondounda; Chinenye Ilozue; Caroline Magne
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

Review 7.  Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review.

Authors:  Amir Abdallah; Jonathan L Chang; Cumara B O'Carroll; Abdu Musubire; Felicia C Chow; Anthony L Wilson; Mark J Siedner
Journal:  J Stroke Cerebrovasc Dis       Date:  2018-04-05       Impact factor: 2.677

Review 8.  Cognitive impairment in patients with AIDS - prevalence and severity.

Authors:  Crystal C Watkins; Glenn J Treisman
Journal:  HIV AIDS (Auckl)       Date:  2015-01-29

9.  HIV-Associated Central Nervous System Disease in Patients Admitted at the Douala General Hospital between 2004 and 2009: A Retrospective Study.

Authors:  Henry Namme Luma; Benjamin Clet Nguenkam Tchaleu; Elvis Temfack; Marie Solange Doualla; Daniela Pamela Ntchankam Ndenga; Yacouba Njankouo Mapoure; Alfred Kinyuy Njamnshi; Vincent-de-Paul Djientcheu
Journal:  AIDS Res Treat       Date:  2013-02-26

10.  Cryptococcal meningoencephalitis in human immunodeficiency virus/acquired immunodeficiency syndrome in douala, cameroon: a cross sectional study.

Authors:  Henry Namme Luma; Elvis Temfack; Marie Patrice Halle; Benjamin Clet Nguenkam Tchaleu; Yacouba Njankouo Mapoure; Sinata Koulla-Shiro
Journal:  N Am J Med Sci       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.